This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

LifePoint's CEO Discusses Q4 2011 Results - Earnings Call Transcript

William Carpenter

Thank you. And welcome everyone to LifePoint Hospital’s fourth quarter and full year 2011 earnings call. We hope you’ve had a chance to review the press release we issued earlier this morning. After my initial remarks Jeff Sherman, our Chief Financial Officer will discuss in detail LifePoint’s results for the fourth quarter and the full year, as well as our outlook for 2012. After our prepared remarks, Jeff and I, as well as David Dill, our President and Chief Operating Officer will be here to answer your questions.

Let me begin by summarizing our results for the fourth quarter. Revenues from continuing operations grew to $781million, up 6.6% from the same period last year. As Jeff will discuss in more detail, we adopted an accounting change that directly impacts the classification of bad debt in our revenue line.

Absent this change, we would have recorded revenues from continuing operations of $916 million. EBIDTA for the quarter was $130 million, up 4.6% over last year and EPS for the quarter was $0.78, up 11.4% over last year.

For the year, revenues from continuing operations were up 7.4%, compared to 2010, EBIDTA was up 7.2% over the prior year and EPS was up 10.7% over the same period.

In 2011, our strong balance sheet and cash flows, as well as our ample liquidity allowed us to make strategic investments to grow organically and through acquisitions. In addition, we repurchased $169 million of common stock in the year. We continued to develop significant resources to acquisitions, service line development and position recruiting.

In the fourth quarter, admissions from continuing operations were up 1.4% and adjusted admissions were up 3.4% versus 2010.

In addition to the solid financial results we achieved in 2011, there are other key accomplishments I would like to mention briefly. In 2011, we improved our core measure inpatient satisfaction results. We successfully integrated new acquisitions into the company and we launched the LifePoint Learning Academy, designed to train and develop leaders within our company especially leaders at the hospitals.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,200.42 -88.21 -0.48%
S&P 500 2,108.25 -9.14 -0.43%
NASDAQ 4,978.6030 -29.4930 -0.59%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs